Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


23.04.2018

1 Am J Hematol
5 Blood
5 Br J Haematol
2 Eur J Haematol
1 Int J Cancer
1 J Clin Oncol
5 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. PARDAL E, Diez Baeza E, Salas Q, Garcia T, et al
    Which very elderly diffuse large B-cell lymphoma patients can benefit from curative treatment? A multicenter, retrospective analysis by the Spanish GELTAMO group.
    Am J Hematol. 2018 Apr 15. doi: 10.1002/ajh.25107.
    PubMed     Text format     Abstract available


    Blood

  2. CHUNG BM, Zieske AW
    Testicular double-hit lymphoma in a patient with history of follicular lymphoma with high proliferation index.
    Blood. 2018;131:1874.
    PubMed     Text format    

  3. BACHY E, Maurer MJ, Habermann TM, Gelas-Dore B, et al
    A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
    Blood. 2018 Apr 17. pii: blood-2017-11-816405. doi: 10.1182/blood-2017-11-816405
    PubMed     Text format     Abstract available

  4. KUPPERS R, Stevenson FK
    Critical influences on the pathogenesis of follicular lymphoma.
    Blood. 2018 Apr 17. pii: blood-2017-11-764365. doi: 10.1182/blood-2017-11-764365
    PubMed     Text format     Abstract available

  5. PASQUALUCCI L, Dalla-Favera R
    Genetics of diffuse large B cell lymphoma.
    Blood. 2018 Apr 17. pii: blood-2017-11-764332. doi: 10.1182/blood-2017-11-764332
    PubMed     Text format     Abstract available

  6. PUENTE XS, Jares P, Campo E
    Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions.
    Blood. 2018 Apr 17. pii: blood-2017-10-764373. doi: 10.1182/blood-2017-10-764373
    PubMed     Text format     Abstract available


    Br J Haematol

  7. FEDERICO M, Bellei M, Marcheselli L, Schwartz M, et al
    Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
    Br J Haematol. 2018 Apr 19. doi: 10.1111/bjh.15258.
    PubMed     Text format     Abstract available

  8. MALIK B, Taylor GP
    Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom.
    Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15234.
    PubMed     Text format    

  9. FRIDTHJOF KS, Kampmann P, Dunweber A, Gorlov JS, et al
    Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
    Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15249.
    PubMed     Text format     Abstract available

  10. KARIMI P, Birmann BM, Anderson LA, McShane CM, et al
    Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.
    Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15229.
    PubMed     Text format     Abstract available

  11. CHIN CK, Tsang E, Mediwake H, Khair W, et al
    Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement.
    Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15173.
    PubMed     Text format    


    Eur J Haematol

  12. MEISTER A, Hentrich M, Wyen C, Hubel K, et al
    Malignant lymphoma in the HIV-positive patient.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13082.
    PubMed     Text format     Abstract available

  13. GRIGNANO E, Laurent J, Deau B, Burroni B, et al
    The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high risk diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13080.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. VERMEULEN R, Saberi Hosnijeh F, Bodinier B, Portengen L, et al
    Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma; univariate and functionally-informed multivariate analyses.
    Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31536.
    PubMed     Text format     Abstract available


    J Clin Oncol

  15. MAURER MJ, Ghesquieres H, Link BK, Jais JP, et al
    Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.
    J Clin Oncol. 2018 Apr 19:JCO2017765198. doi: 10.1200/JCO.2017.76.5198.
    PubMed     Text format     Abstract available


    N Engl J Med

  16. CANELLOS GP, LaCasce AS
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1560.
    PubMed     Text format    

  17. CRUMP M
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559-60.
    PubMed     Text format    

  18. GREER JP
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559.
    PubMed     Text format    

  19. HILAL T
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-9.
    PubMed     Text format    


  20. Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-1561.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: